Neurologic complications of psychomotor stimulant abuse

International Review of Neurobiology

Volumn 120, Issue , 2015, Pages 131-160

  Sanchez Ramos, Juan ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE DERIVATIVE; COCAINE; METHAMPHETAMINE; PSYCHOSTIMULANT AGENT; CENTRAL STIMULANT AGENT;

ATHETOSIS; CEREBROVASCULAR ACCIDENT; CHOREA; DRUG ABUSE; DRUG TOLERANCE; DYSKINESIA; DYSTONIA; EMERGENCY CARE; HOSPITALIZATION; HUMAN; HYPERPYREXIA; MOTOR DYSFUNCTION; NEUROLOGICAL COMPLICATION; NEUROPHARMACOLOGY; NEUROPSYCHOLOGY; PARKINSON DISEASE; PRIORITY JOURNAL; RHABDOMYOLYSIS; SEIZURE; STEREOTYPY; TIC; ADDICTION; CHEMICALLY INDUCED; FEVER; PSYCHOLOGY;

CENTRAL NERVOUS SYSTEM STIMULANTS; DRUG TOLERANCE; DYSKINESIA, DRUG-INDUCED; FEVER; HUMANS; RHABDOMYOLYSIS; SEIZURES; STROKE; SUBSTANCE-RELATED DISORDERS;

EID: 84943352616     PISSN: 00747742     EISSN: 21625514     Source Type: Book Series    
DOI: 10.1016/bs.irn.2015.02.003     Document Type: Chapter

References (139)

1. Abourashed, E. A., El-Alfy, A. T., Khan, I. A., & Walker, L. (2003). Ephedra in perspective-A current review. Phytotherapy Research, 17(7), 703-712. http://dx.doi. org/10.1002/ptr.1337.
2. Albin, R. L., Young, A. B., & Penney, J. B. (1995). The functional anatomy of disorders of the basal ganglia. Trends in Neurosciences, 18(2), 63-64.
3. Aliane, V., Perez, S., Bohren, Y., Deniau, J. M., & Kemel, M. L. (2011). Key role of striatal cholinergic interneurons in processes leading to arrest of motor stereotypies. Brain, 134(Pt. 1), 110-118. http://dx.doi.org/10.1093/brain/awq285.
4. Anglin, M. D., Burke, C., Perrochet, B., Stamper, E., & Dawud-Noursi, S. (2000). History of the methamphetamine problem. Journal of Psychoactive Drugs, 32(2), 137-141. http:// dx.doi.org/10.1080/02791072.2000.10400221.
5. Angrist, B., Lee, H. K., & Gershon, S. (1974). The antagonism of amphetamine-induced symptomatology by a neuroleptic. The American Journal of Psychiatry, 131(7), 817-819.
6. APA. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Arlington, VA: American Psychiatric Publishing.
7. Arsava, E. M., Ballabio, E., Benner, T., Cole, J. W., Delgado-Martinez, M. P., Dichgans, M., et al. (2010). The causative classification of stroke system: An international reliability and optimization study. Neurology, 75(14), 1277-1284. http://dx.doi.org/10.1212/ WNL.0b013e3181f612ce.
8. Ay, H., Benner, T., Arsava, E. M., Furie, K. L., Singhal, A. B., Jensen, M. B., et al. (2007). A computerized algorithm for etiologic classification of ischemic stroke: The causative classification of stroke system. Stroke, 38(11), 2979-2984. http://dx.doi.org/10.1161/ STROKEAHA.107.490896.
9. Bartzokis, G., Beckson, M., Wirshing, D. A., Lu, P. H., Foster, J. A., & Mintz, J. (1999). Choreoathetoid movements in cocaine dependence. Biological Psychiatry, 45(12), 1630-1635.
10. Bell, D. S. (1965). Comparison of amphetamine psychosis and schizophrenia. The British Journal of Psychiatry, 111, 701-707.
11. Boileau, I., Rusjan, P., Houle, S., Wilkins, D., Tong, J., Selby, P., et al. (2008). Increased vesicular monoamine transporter binding during early abstinence in human methamphetamine users: Is VMAT2 a stable dopamine neuron biomarker? The Journal of Neuroscience, 28(39), 9850-9856. http://dx.doi.org/10.1523/JNEUROSCI.3008-08.2008.
12. Buckley, P. F. (1998). Substance abuse in schizophrenia: A review. The Journal of Clinical Psychiatry, 59(Suppl. 3), 26-30.
13. Buttner, A. (2012). Neuropathological alterations in cocaine abuse. Current Medicinal Chemistry, 19(33), 5597-5600.
14. Byck, R. (1974). Introduction. In R. Byck (Ed.), Cocaine papers (p. xvii). New York: Stonehill Publishing.
15. Caligiuri, M. P., & Buitenhuys, C. (2005). Do preclinical findings of methamphetamineinduced motor abnormalities translate to an observable clinical phenotype? Neuropsychopharmacology, 30(12), 2125-2134. http://dx.doi.org/10.1038/sj.npp.1300859.
16. Callaghan, R. C., Cunningham, J. K., Sajeev, G., & Kish, S. J. (2010). Incidence of Parkinson's disease among hospital patients with methamphetamine-use disorders. Movement Disorders, 25(14), 2333-2339. http://dx.doi.org/10.1002/mds.23263.
17. Carvalho, F. (2003). The toxicological potential of khat. Journal of Ethnopharmacology, 87(1), 1-2.
18. Carvalho, M., Carmo, H., Costa, V. M., Capela, J. P., Pontes, H., Remiao, F., et al. (2012). Toxicity of amphetamines: An update. Archives of Toxicology, 86(8), 1167-1231. http:// dx.doi.org/10.1007/s00204-012-0815-5.
19. Chambers, R. A., Krystal, J. H., & Self, D. W. (2001). A neurobiological basis for substance abuse comorbidity in schizophrenia. Biological Psychiatry, 50(2), 71-83.
20. Chen, C. K., Lin, S. K., Sham, P. C., Ball, D., Loh el, W., & Murray, R. M. (2005). Morbid risk for psychiatric disorder among the relatives of methamphetamine users with and without psychosis. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics, 136B(1), 87-91. http://dx.doi.org/10.1002/ajmg.b.30187.
21. Chen, C. K., Lin, S. K., Sham, P. C., Ball, D., Loh, E. W., Hsiao, C. C., et al. (2003). Premorbid characteristics and co-morbidity of methamphetamine users with and without psychosis. Psychological Medicine, 33(8), 1407-1414.
22. Choy-Kwong, M., & Lipton, R. B. (1989a). Dystonia related to cocaine withdrawal: A case report and pathogenic hypothesis. Neurology, 39(7), 996-997.
23. Choy-Kwong, M., & Lipton, R. B. (1989b). Seizures in hospitalized cocaine users. Neurology, 39(3), 425-427.
24. Christine, C. W., Garwood, E. R., Schrock, L. E., Austin, D. E., & McCulloch, C. E. (2010). Parkinsonism in patients with a history of amphetamine exposure. Movement Disorders, 25(2), 228-231. http://dx.doi.org/10.1002/mds.22915.
25. Cogen, F. C., Rigg, G., Simmons, J. L., & Domino, E. F. (1978). Phencyclidine-associated acute rhabdomyolysis. Annals of Internal Medicine, 88(2), 210-212.
26. Cruickshank, C. C., & Dyer, K. R. (2009). A review of the clinical pharmacology of methamphetamine. Addiction, 104(7), 1085-1099. http://dx.doi.org/10.1111/j.1360-0443.2009.02564.x.
27. Daras, M., Koppel, B. S., & Atos-Radzion, E. (1994). Cocaine-induced choreoathetoid movements ('crack dancing'). Neurology, 44(4), 751-752.
28. Derlet, R. W., & Heischober, B. (1990). Methamphetamine. Stimulant of the 1990s? The Western Journal of Medicine, 153(6), 625-628.
29. Desai, R. I., & Bergman, J. (2010). Drug discrimination in methamphetamine-trained rats: Effects of cholinergic nicotinic compounds. The Journal of Pharmacology and Experimental Therapeutics, 335(3), 807-816. http://dx.doi.org/10.1124/jpet.110.173773.
30. Downes, M. A., & Whyte, I. M. (2005). Amphetamine-induced movement disorder. Emergency Medicine Australasia, 17(3), 277-280. http://dx.doi.org/10.1111/j.1742-6723.2005.00735.x.
31. European Monitoring Centre for Drugs and Drug Addiction. (2007). Cocaine and crack cocaine: A growing public health issue. Luxembourg. Retrieved from, http://www.emcdda.europa. eu/attachements.cfm/att_44748_EN_TDSI07002ENC.pdf.
32. Fasano, A., Barra, A., Nicosia, P., Rinaldi, F., Bria, P., Bentivoglio, A. R., et al. (2008). Cocaine addiction: From habits to stereotypical-repetitive behaviors and punding. Drug and Alcohol Dependence, 96(1-2), 178-182. http://dx.doi.org/10.1016/j.drugalcdep. 2008.02.005.
33. Fasano, A., & Petrovic, I. (2010). Insights into pathophysiology of punding reveal possible treatment strategies. Molecular Psychiatry, 15(6), 560-573. http://dx.doi.org/10.1038/ mp.2009.95.
34. Ferro, J. M., Massaro, A. R., & Mas, J. L. (2010). Aetiological diagnosis of ischaemic stroke in young adults. Lancet Neurology, 9(11), 1085-1096. http://dx.doi.org/10.1016/S1474-4422(10)70251-9.
35. Fiala, M., Gan, X. H., Zhang, L., House, S. D., Newton, T., Graves, M. C., et al. (1998). Cocaine enhances monocyte migration across the blood-brain barrier. Cocaine's connection to AIDS dementia and vasculitis? Advances in Experimental Medicine and Biology, 437, 199-205.
36. Fischman, M. W., Schuster, C. R., Resnekov, L., Shick, J. F., Krasnegor, N. A., Fennell, W., et al. (1976). Cardiovascular and subjective effects of intravenous cocaine administration in humans. Archives of General Psychiatry, 33(8), 983-989.
37. Fleckenstein, A. E., Volz, T. J., Riddle, E. L., Gibb, J. W., & Hanson, G. R. (2007). New insights into the mechanism of action of amphetamines. Annual Review of Pharmacology and Toxicology, 47, 681-698. http://dx.doi.org/10.1146/annurev.pharmtox.47. 120505.105140.
38. Fox, A. W. (1989). More on rhabdomyolysis associated with cocaine intoxication. The New England Journal of Medicine, 321(18), 1271.
39. Gan, X., Zhang, L., Berger, O., Stins, M. F., Way, D., Taub, D. D., et al. (1999). Cocaine enhances brain endothelial adhesion molecules and leukocyte migration. Clinical Immunology, 91(1), 68-76. http://dx.doi.org/10.1006/clim.1998.4683.
40. Garwood, E. R., Bekele, W., McCulloch, C. E., & Christine, C. W. (2006). Amphetamine exposure is elevated in Parkinson's disease. Neurotoxicology, 27(6), 1003-1006. http://dx. doi.org/10.1016/j.neuro.2006.03.015.
41. Gawin, F. H. (1991). Cocaine addiction: Psychology and neurophysiology. Science, 251(5001), 1580-1586.
42. Gawin, F. H., & Ellinwood, E. H., Jr. (1988). Cocaine and other stimulants. Actions, abuse, and treatment. The New England Journal of Medicine, 318(18), 1173-1182. http://dx.doi. org/10.1056/NEJM198805053181806.
43. Gay, G. R. (1982). Clinical management of acute and chronic cocaine poisoning. Annals of Emergency Medicine, 11(10), 562-572.
44. Gilbert, S. J., & Burgess, P. W. (2008). Executive function. Current Biology, 18(3), R110-R114. http://dx.doi.org/10.1016/j.cub.2007.12.014.
45. Gollub, R. L., Breiter, H. C., Kantor, H., Kennedy, D., Gastfriend, D., Mathew, R. T., et al. (1998). Cocaine decreases cortical cerebral blood flow but does not obscure regional activation in functional magnetic resonance imaging in human subjects. Journal of Cerebral Blood Flow and Metabolism, 18(7), 724-734. http://dx.doi.org/10.1097/00004647-199807000-00003.
46. Gonzales, R., Mooney, L., & Rawson, R. A. (2010). The methamphetamine problem in the United States. Annual Review of Public Health, 31, 385-398. http://dx.doi.org/10.1146/ annurev.publhealth.012809.103600.
47. Guilarte, T. R. (2001). Is methamphetamine abuse a risk factor in parkinsonism? Neurotoxicology, 22(6), 725-731.
48. Halpin, L. E., Collins, S. A., & Yamamoto, B. K. (2014). Neurotoxicity of methamphetamine and 3,4-methylenedioxymethamphetamine. Life Sciences, 97(1), 37-44. http:// dx.doi.org/10.1016/j.lfs.2013.07.014.
49. Hard, C. (1989). Acute rhabdomyolysis associated with cocaine intoxication. The New England Journal of Medicine, 320(10), 667-668. http://dx.doi.org/10.1056/ NEJM198903093201011.
50. Hearn, W. L., Flynn, D. D., Hime, G. W., Rose, S., Cofino, J. C., Mantero-Atienza, E., et al. (1991). Cocaethylene: A unique cocaine metabolite displays high affinity for the dopamine transporter. Journal of Neurochemistry, 56(2), 698-701.
51. Heesch, C. M., Wilhelm, C. R., Ristich, J., Adnane, J., Bontempo, F. A., & Wagner, W. R. (2000). Cocaine activates platelets and increases the formation of circulating platelet containing microaggregates in humans. Heart, 83(6), 688-695.
52. Hernan, M. A., Takkouche, B., Caamano-Isorna, F., & Gestal-Otero, J. J. (2002). A metaanalysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease. Annals of Neurology, 52(3), 276-284. http://dx.doi.org/10.1002/ana.10277.
53. Herning, R. I., Better, W., Nelson, R., Gorelick, D.,&Cadet, J. L. (1999). The regulation of cerebral blood flow during intravenous cocaine administration in cocaine abusers. Annals of the New York Academy of Sciences, 890, 489-494.
54. Hobbs, W. E., Moore, E. E., Penkala, R. A., Bolgiano, D. D.,&Lopez, J. A. (2013). Cocaine and specific cocaine metabolites induce von Willebrand factor release from endothelial cells in a tissue-specific manner. Arteriosclerosis, Thrombosis, and Vascular Biology, 33(6), 1230-1237. http://dx.doi.org/10.1161/ATVBAHA.113.301436.
55. Inaba, T., Stewart, D. J., & Kalow, W. (1978). Metabolism of cocaine in man. Clinical Pharmacology and Therapeutics, 23(5), 547-552.
56. Iwanami, A., Sugiyama, A., Kuroki, N., Toda, S., Kato, N., Nakatani, Y., et al. (1994). Patients with methamphetamine psychosis admitted to a psychiatric hospital in Japan. A preliminary report. Acta Psychiatrica Scandinavica, 89(6), 428-432.
57. Jaffe, J. (1985). Drug addiction and drug abuse. In G. L. Goodman, A. Gilman, T. W. Rall, & F. Murad (Eds.), Pharmacological basis of therapeutics (7th ed., pp. 532-581). New York: MacMillan Publishing Company.
58. Johanson, C. E., Frey, K. A., Lundahl, L. H., Keenan, P., Lockhart, N., Roll, J., et al. (2006). Cognitive function and nigrostriatal markers in abstinent methamphetamine abusers. Psychopharmacology, 185(3), 327-338. http://dx.doi.org/10.1007/s00213-006-0330-6.
59. Johnson, B., Lamki, L., Fang, B., Barron, B., Wagner, L., Wells, L., et al. (1998). Demonstration of dose-dependent global and regional cocaine-induced reductions in brain blood flow using a novel approach to quantitative single photon emission computerized tomography. Neuropsychopharmacology, 18(5), 377-384. http://dx.doi.org/10.1016/ S0893-133X(97)00168-1.
60. Kendrick, W. C., Hull, A. R., & Knochel, J. P. (1977). Rhabdomyolysis and shock after intravenous amphetamine administration. Annals of Internal Medicine, 86(4), 381-387. http://dx.doi.org/10.1089/ten.2005.11.1085.
61. Klawans, H. L., & Weiner, W. J. (1974). The effect of d-amphetamine on choreiform movement disorders. Neurology, 24(4), 312-318.
62. Kleven, M. S., & Seiden, L. S. (1992). Methamphetamine-induced neurotoxicity: Structure activity relationships. Annals of the New York Academy of Sciences, 654, 292-301.
63. Knochel, J. P. (1981). Serum calcium derangements in rhabdomyolysis. The New England Journal of Medicine, 305(3), 161-163. http://dx.doi.org/10.1056/ NEJM198107163050307.
64. Knuepfer, M. M., Rowe, K. D., Schwartz, J. A., & Lomax, L. L. (2005). Role of angiotensin II and corticotropin-releasing hormone in hemodynamic responses to cocaine and stress. Regulatory Peptides, 127(1-3), 1-10. http://dx.doi.org/10.1016/j.regpep.2004.12.010.
65. Konno, C., Taguchi, T., Tamada, M., & Hikino, H. (1979). Ephedroxane, antiinflammatory principle of Ephedra herbs. Phytochemistry, 18, 697-698.
66. Kumor, K., Sherer, M., & Jaffe, J. (1986). Haloperidol-induced dystonia in cocaine addicts. Lancet, 2(8519), 1341-1342.
67. Lake, C. R., & Quirk, R. S. (1984). CNS stimulants and the look-alike drugs. The Psychiatric Clinics of North America, 7(4), 689-701.
68. Lieberman, J. A., Kinon, B. J., & Loebel, A. D. (1990). Dopaminergic mechanisms in idiopathic and drug-induced psychoses. Schizophrenia Bulletin, 16(1), 97-110.
69. Lowenstein, D. H., Massa, S. M., Rowbotham, M. C., Collins, S. D., McKinney, H. E., & Simon, R. P. (1987). Acute neurologic and psychiatric complications associated with cocaine abuse. The American Journal of Medicine, 83(5), 841-846.
70. Lucena, J., Blanco, M., Jurado, C., Rico, A., Salguero, M., Vazquez, R., et al. (2010). Cocaine-related sudden death: A prospective investigation in south-west Spain. European Heart Journal, 31(3), 318-329. http://dx.doi.org/10.1093/eurheartj/ehp557.
71. Lundh, H., & Tunving, K. (1981). An extrapyramidal choreiform syndrome caused by amphetamine addiction. Journal of Neurology, Neurosurgery, and Psychiatry, 44(8), 728-730.
72. Madden, J. A., & Powers, R. H. (1990). Effect of cocaine and cocaine metabolites on cerebral arteries in vitro. Life Sciences, 47(13), 1109-1114.
73. Mahoney, J. J., 3rd., Kalechstein, A. D., De La Garza, R., 2nd., & Newton, T. F. (2008). Presence and persistence of psychotic symptoms in cocaine- versus methamphetamine-dependent participants. The American Journal on Addictions, 17(2), 83-98. http://dx.doi.org/10.1080/10550490701861201.
74. Mathew, R. J., Wilson, W. H., Lowe, J. V., & Humphries, D. (1996). Acute changes in cranial blood flow after cocaine hydrochloride. Biological Psychiatry, 40(7), 609-616.
75. Matsumoto, R. R., Seminerio, M. J., Turner, R. C., Robson, M. J., Nguyen, L., Miller, D. B., et al. (2014). Methamphetamine-induced toxicity: An updated review on issues related to hyperthermia. Pharmacology & Therapeutics, 144(1), 28-40. http:// dx.doi.org/10.1016/j.pharmthera.2014.05.001.
76. Matsumura, K., Tsuchihashi, T., & Abe, I. (2001). Central human cocaine- and amphetamine-regulated transcript peptide 55-102 increases arterial pressure in conscious rabbits. Hypertension, 38(5), 1096-1100.
77. McCann, U. D., Kuwabara, H., Kumar, A., Palermo, M., Abbey, R., Brasic, J., et al. (2008). Persistent cognitive and dopamine transporter deficits in abstinent methamphetamine users. Synapse, 62(2), 91-100. http://dx.doi.org/10.1002/syn.20471.
78. Merab, J. (1988). Acute dystonic reaction to cocaine. The American Journal of Medicine, 84(3 Pt. 1), 564.
79. Merkel, P. A., Koroshetz, W. J., Irizarry, M. C., & Cudkowicz, M. E. (1995). Cocaineassociated cerebral vasculitis. Seminars in Arthritis and Rheumatism, 25(3), 172-183.
80. Mittleman, R. E., & Wetli, C. V. (1984). Death caused by recreational cocaine use. An update. JAMA, 252(14), 1889-1893.
81. Mo, W., Arruda, J. A., Dunea, G., & Singh, A. K. (1999). Cocaine-induced hypertension: Role of the peripheral sympathetic system. Pharmacological Research, 40(2), 139-145. http://dx.doi.org/10.1006/phrs.1999.0503.
82. Morgan, J. C., Winter, W. C., & Wooten, G. F. (2004). Amphetamine-induced chorea in attention deficit-hyperactivity disorder. Movement Disorders, 19(7), 840-842. http://dx. doi.org/10.1002/mds.20081.
83. Moszczynska, A., Fitzmaurice, P., Ang, L., Kalasinsky, K. S., Schmunk, G. A., Peretti, F. J., et al. (2004). Why is parkinsonism not a feature of human methamphetamine users? Brain, 127(Pt. 2), 363-370. http://dx.doi.org/10.1093/brain/awh046.
84. Nakamura, K., Nakagawa, H., Sakurai, M., Murakami, Y., Irie, F., Fujiyoshi, A., et al. (2012). Influence of smoking combined with another risk factor on the risk of mortality from coronary heart disease and stroke: Pooled analysis of 10 Japanese cohort studies. Cerebrovascular Diseases, 33(5), 480-491. http://dx.doi.org/10.1159/000336764.
85. National Institute of Neurological Disorders and Stroke, NIH. (2012). Final Report of the Stroke Progress Review Group-January 2012. National Institute of Neurological Disorders and Stroke (NINDS-NIH). Retrieved from http://www.ninds.nih.gov/about_ninds/ groups/stroke_prg/2012-stroke-prg-full-report.htm.
86. NIDA. (2011). Drug facts: Drug-related hospital emergency room visits. Rockville, MD: Drug Abuse Warning Network (DAWN).
87. NIDA. (2014). Nationwide trends in drug abuse. from, http://www.drugabuse.gov/ publications/drugfacts/nationwide-trends.
88. Nolte, K. B. (1991). Rhabdomyolysis associated with cocaine abuse. Human Pathology, 22(11), 1141-1145.
89. O'Connor, A. D., Rusyniak, D. E., & Bruno, A. (2005). Cerebrovascular and cardiovascular complications of alcohol and sympathomimetic drug abuse. The Medical Clinics of North America, 89(6), 1343-1358. http://dx.doi.org/10.1016/j.mcna.2005.06.010.
90. O'Donnell, M. J., Xavier, D., Liu, L., Zhang, H., Chin, S. L., Rao-Melacini, P., et al. (2010). Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet, 376(9735), 112-123. http://dx.doi.org/10.1016/S0140-6736(10)60834-3.
91. Office of National Drug Control Policy. (2011). America's drug use profile. http://www.ncjrs. gov/ondcppubs/publications/policy/ndcs01/chap2.html.
92. O'Leary, M. E., & Hancox, J. C. (2010). Role of voltage-gated sodium, potassium and calcium channels in the development of cocaine-associated cardiac arrhythmias. British Journal of Clinical Pharmacology, 69(5), 427-442. http://dx.doi.org/10.1111/j.1365-2125.2010.03629.x.
93. O'Sullivan, S. S., Evans, A. H., & Lees, A. J. (2009). Dopamine dysregulation syndrome: An overview of its epidemiology, mechanisms and management. CNS Drugs, 23(2), 157-170. http://dx.doi.org/10.2165/00023210-200923020-00005.
94. Pascual-Leone, A., Dhuna, A., Altafullah, I., & Anderson, D. C. (1990). Cocaine-induced seizures. Neurology, 40(3 Pt. 1), 404-407.
95. Patra, J., Taylor, B., Irving, H., Roerecke, M., Baliunas, D., Mohapatra, S., et al. (2010). Alcohol consumption and the risk of morbidity and mortality for different stroke types-A systematic review and meta-analysis. BMC Public Health, 10, 258. http://dx. doi.org/10.1186/1471-2458-10-258.
96. Peng, W., & Duan, S. F. (1989). The acute effects of ligustrazini on hemodynamics and right cardiac function in pulmonary arterial hypertension secondary to chronic obstructive pulmonary disease. Journal of Tongji Medical University, 9(2), 100-102.
97. Pierce, R. C., & Kalivas, P. W. (1997). A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Research. Brain Research Reviews, 25(2), 192-216.
98. Pulay, E. (1922). Cocaine poisoning. JAMA, 78, 1855.
99. Randrup, A., & Munkvad, I. (1967). Stereotyped activities produced by amphetamine in several animal species and man. Psychopharmacologia, 11(4), 300-310.
100. Rhee, K. J., Albertson, T. E., & Douglas, J. C. (1988). Choreoathetoid disorder associated with amphetamine-like drugs. The American Journal of Emergency Medicine, 6(2), 131-133.
101. Rinder, H. M., Ault, K. A., Jatlow, P. I., Kosten, T. R., & Smith, B. R. (1994). Platelet alpha-granule release in cocaine users. Circulation, 90(3), 1162-1167.
102. Rippeth, J. D., Heaton, R. K., Carey, C. L., Marcotte, T. D., Moore, D. J., Gonzalez, R., et al. (2004). Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons. Journal of the International Neuropsychological Society, 10(1), 1-14. http://dx.doi.org/10.1017/S1355617704101021.
103. Ritchie, J. M., & Greene, N. M. (1985). Local anesthetics. In A. G. Gilman, L. S. Goodman, & T. W. Rall (Eds.), The pharmacological basis of therapeutics (p. 302). New York: MacMillan.
104. Ritz, M. C., Lamb, R. J., Goldberg, S. R., & Kuhar, M. J. (1987). Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science, 237(4819), 1219-1223.
105. Ross, B. M., Moszczynska, A., Peretti, F. J., Adams, V., Schmunk, G. A., Kalasinsky, K. S., et al. (2002). Decreased activity of brain phospholipid metabolic enzymes in human users of cocaine and methamphetamine. Drug and Alcohol Dependence, 67(1), 73-79.
106. Roth, D., Alarcon, F. J., Fernandez, J. A., Preston, R. A., & Bourgoignie, J. J. (1988). Acute rhabdomyolysis associated with cocaine intoxication. The New England Journal of Medicine, 319(11), 673-677. http://dx.doi.org/10.1056/NEJM198809153191103.
107. Rothwell, P. M., Howard, S. C., Dolan, E., O'Brien, E., Dobson, J. E., Dahlof, B., et al. (2010). Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet, 375(9718), 895-905. http://dx.doi.org/ 10.1016/S0140-6736(10)60308-X.
108. Rumbaugh, C. L., Bergeron, R. T., Scanlan, R. L., Teal, J. S., Segall, H. D., Fang, H. C., et al. (1971). Cerebral vascular changes secondary to amphetamine abuse in the experimental animal. Radiology, 101(2), 345-351. http://dx.doi.org/10.1148/101.2.345.
109. Russell, R. D., & Stripling, J. S. (1987). Monoaminergic and local anesthetic components of cocaine's effects on kindled seizure expression. Pharmacology, Biochemistry, and Behavior, 22, 427-434.
110. Rusyniak, D. E. (2011). Neurologic manifestations of chronic methamphetamine abuse. Neurologic Clinics, 29(3), 641-655. http://dx.doi.org/10.1016/j.ncl.2011.05.004.
111. Rusyniak, D. E. (2013). Neurologic manifestations of chronic methamphetamine abuse. The Psychiatric Clinics of North America, 36(2), 261-275. http://dx.doi.org/10.1016/ j.psc.2013.02.005.
112. Rylander, G. (1972). Psychoses and the punding and choreiform syndromes in addiction to central stimulant drugs. Psychiatria, Neurologia, Neurochirurgia, 75(3), 203-212.
113. Sanchez-Ramos, J. R. (1993). Psychostimulants. Neurologic Clinics, 11(3), 535-553.
114. Sato, M. (1992). A lasting vulnerability to psychosis in patients with previous methamphetamine psychosis. Annals of the New York Academy of Sciences, 654, 160-170.
115. Schep, L. J., Slaughter, R. J., & Beasley, D. M. (2010). The clinical toxicology of metamfetamine. Clinical Toxicology (Philadelphia, Pa.), 48(7), 675-694. http://dx.doi.org/ 10.3109/15563650.2010.516752.
116. Scott, J. C., Woods, S. P., Matt, G. E., Meyer, R. A., Heaton, R. K., Atkinson, J. H., et al. (2007). Neurocognitive effects of methamphetamine: A critical review and metaanalysis. Neuropsychology Review, 17(3), 275-297. http://dx.doi.org/10.1007/s11065-007-9031-0.
117. Shuster, L., Garhart, C. A., Powers, J., Grunfeld, Y., & Kanel, G. (1988). Hepatotoxicity of cocaine. NIDA Research Monograph, 88, 250-275.
118. Sordo, L., Indave, B. I., Barrio, G., Degenhardt, L., de la Fuente, L., & Bravo, M. J. (2014). Cocaine use and risk of stroke: A systematic review. Drug and Alcohol Dependence, 142, 1-13. http://dx.doi.org/10.1016/j.drugalcdep.2014.06.041.
119. Sperling, L. S., & Horowitz, J. L. (1994). Methamphetamine-induced choreoathetosis and rhabdomyolysis. Annals of Internal Medicine, 121(12), 986.
120. Srisurapanont, M., Ali, R., Marsden, J., Sunga, A., Wada, K., & Monteiro, M. (2003). Psychotic symptoms in methamphetamine psychotic in-patients. The International Journal of Neuropsychopharmacology, 6(4), 347-352. http://dx.doi.org/10.1017/S1461145703003675.
121. Stork, C. M., & Cantor, R. (1997). Pemoline induced acute choreoathetosis: Case report and review of the literature. Journal of Toxicology. Clinical Toxicology, 35(1), 105-108.
122. Stripling, J. S. (1983). Cocaine and "pharmacological kindling" in the rat. Experimental Neurology, 82(2), 499-503.
123. Su, J., Li, J., Li, W., Altura, B. T., & Altura, B. M. (2003). Cocaine induces apoptosis in cerebral vascular muscle cells: Potential roles in strokes and brain damage. European Journal of Pharmacology, 482(1-3), 61-66.
124. Suwaki, H., Fukui, S., & Konuma, K. (1997). Methamphetamine abuse in Japan: Its 45 year history and the current situation. In H. Klee (Ed.), Amphetamine misuse: International perspectives on current trends. Reading, UK: Harwood Academic Publisher.
125. Suzuki, O., Hattori, H., Asano, M., Oya, M., & Katsumata, Y. (1980). Inhibition of monoamine oxidase by d-methamphetamine. Biochemical Pharmacology, 29(14), 2071-2073.
126. Truong, J. G., Wilkins, D. G., Baudys, J., Crouch, D. J., Johnson-Davis, K. L., Gibb, J. W., et al. (2005). Age-dependent methamphetamine-induced alterations in vesicular monoamine transporter-2 function: Implications for neurotoxicity. The Journal of Pharmacology and Experimental Therapeutics, 314(3), 1087-1092. http://dx.doi.org/10.1124/ jpet.105.085951.
127. Tulving, E. (2002). Episodic memory: From mind to brain. Annual Review of Psychology, 53, 1-25. http://dx.doi.org/10.1146/annurev.psych.53.100901.135114.
128. UNDOC. (2008). Annual report 2008. http://www.unodc.org/documents/about-unodc/ AR08_WEB.pdf.
129. Volkow, N. D., Chang, L., Wang, G. J., Fowler, J. S., Ding, Y. S., Sedler, M., et al. (2001). Low level of brain dopamine D2 receptors in methamphetamine abusers: Association with metabolism in the orbitofrontal cortex. The American Journal of Psychiatry, 158(12), 2015-2021.
130. Volkow, N. D., Chang, L., Wang, G. J., Fowler, J. S., Franceschi, D., Sedler, M., et al. (2001). Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence. The Journal of Neuroscience, 21(23), 9414-9418.
131. Volkow, N. D., Chang, L., Wang, G. J., Fowler, J. S., Leonido-Yee, M., Franceschi, D., et al. (2001). Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. The American Journal of Psychiatry, 158(3), 377-382.
132. Weinberger, A. H., & Sofuoglu, M. (2009). The impact of cigarette smoking on stimulant addiction. The American Journal of Drug and Alcohol Abuse, 35(1), 12-17. http://dx.doi. org/10.1080/00952990802326280.
133. Weiner, W. J., & Sanchez-Ramos, J. (1992). Movement disorders and dopaminomimetic stimulant drugs. In A. E. Lang, & W. J. Weiner (Eds.), Drug induced movement disorders (pp. 315-337). Mount Kisco, NY: Futura Publishing Co.
134. Westover, A. N., McBride, S., & Haley, R. W. (2007). Stroke in young adults who abuse amphetamines or cocaine: A population-based study of hospitalized patients. Archives of General Psychiatry, 64(4), 495-502. http://dx.doi.org/10.1001/archpsyc.64.4.495.
135. Wilson, J. M., Kalasinsky, K. S., Levey, A. I., Bergeron, C., Reiber, G., Anthony, R. M., et al. (1996). Striatal dopamine nerve terminal markers in human, chronic methamphetamine users. Nature Medicine, 2(6), 699-703.
136. Yamamoto, B. K., Moszczynska, A., & Gudelsky, G. A. (2010). Amphetamine toxicities: Classical and emerging mechanisms. Annals of the New York Academy of Sciences, 1187, 101-121. http://dx.doi.org/10.1111/j.1749-6632.2009.05141.x.
137. Yonetani, M., Huang, C. C., Lajevardi, N., Pastuszko, A., Delivoria-Papadopoulous, M., & Anday, E. (1994). Effect of acute cocaine injection on the extracellular level of dopamine, blood flow, and oxygen pressure in brain of newborn piglets. Biochemical Medicine and Metabolic Biology, 51(1), 91-97.
138. Young, R., & Glennon, R. A. (1986). Discriminative stimulus properties of amphetamine and structurally related phenalkylamines. Medicinal Research Reviews, 6(1), 99-130.
139. Yui, K., Ikemoto, S., Ishiguro, T., & Goto, K. (2000). Studies of amphetamine or methamphetamine psychosis in Japan: Relation of methamphetamine psychosis to schizophrenia. Annals of the New York Academy of Sciences, 914, 1-12.